Hongmei Han - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hongmei Han

Showing results (81-90 of 85) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 85 results.

Journal of Behavioral Medicine|March 3, 2010

Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST studyDonald A Williamson, Stephen D Anton, Hongmei Han, et al.

American Journal of Cancer Research|September 11, 2023

Clinical outcomes of radioactive seed brachytherapy and microwave ablation in inoperable stage I non-small cell lung cancerZhe Ji, Yang Ni, Chuang He, et al.

Clinical Lymphoma, Myeloma & Leukemia|February 25, 2025

A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic MalignanciesMichal Kwiatek, Guru Subramanian Guru Murthy, Marc Hoffmann, et al.

The New England Journal of Medicine|October 23, 2023

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Benjamin Solomon, Herbert H Loong, et al.

Haematologica|October 4, 2024

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trialNirav N Shah, Michael Wang, Lindsey E Roeker, et al.

Pageof 9

Search research articles

Showing results (81-90 of 85) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 85 results.

Journal of Behavioral Medicine|March 3, 2010

Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST studyDonald A Williamson, Stephen D Anton, Hongmei Han, et al.

American Journal of Cancer Research|September 11, 2023

Clinical outcomes of radioactive seed brachytherapy and microwave ablation in inoperable stage I non-small cell lung cancerZhe Ji, Yang Ni, Chuang He, et al.

Clinical Lymphoma, Myeloma & Leukemia|February 25, 2025

A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic MalignanciesMichal Kwiatek, Guru Subramanian Guru Murthy, Marc Hoffmann, et al.

The New England Journal of Medicine|October 23, 2023

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Benjamin Solomon, Herbert H Loong, et al.

Haematologica|October 4, 2024

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trialNirav N Shah, Michael Wang, Lindsey E Roeker, et al.

Pageof 9